Drivers of cancer development: the inflammatory messenger oncostatin M...Charité - Universitätsmedizin Berlin
Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimen Improves Outcomes in Stage 3 Colon Cancer, Study Fin...Dana-Farber Cancer Institute